Alzheimer Archives

Alzheimer's disease, the most common form of dementia, affects over six million Americans and millions more worldwide. It's a debilitating condition with no known cure. However, medical advancements have given rise to Leqembi, a drug capable of delaying Alzheimer's progression by a few months when administered to patients exhibiting mild symptoms. Leqembi works by clearing a sticky brain protein called amyloid, a key indicator of Alzheimer's disease. Despite its groundbreaking potential, the drug's impact is limited and it can cause side effects such as brain swelling and bleeding, requiring regular brain scans to monitor these potential complications. Despite its promise, Leqembi's sales have been lackluster since its U.S. market debut. Major hospital systems have taken months to st...

Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Detecting this disease in its early stages is crucial for effective treatment and management. Traditionally, brain imaging techniques such as MRI scans and PET imaging have been used for diagnosis. However, these methods can be expensive and not widely accessible. Excitingly, recent breakthrough research has shown that a simple blood test may hold the key to detecting Alzheimer's disease up to 15 years before symptoms manifest. Current diagnostic methods for Alzheimer's disease rely on the identification of amyloid and tau proteins, which form characteristic plaques and tangles in the brain. While brain imaging and spinal taps can provide insights into these proteins, they are inva...

Tag: Alzheimer

Understanding the Slow Progress of Alzheimer’s Disease Medication

Alzheimer’s Blood Test That Can Detect the Disease Before Symptoms